Literature DB >> 15038775

Antagonistic effects of simultaneous exposure of ergot alkaloids on kidney adenosine triphosphatase system.

Ali S Moubarak1, Zelpha B Johnson, Charles F Rosenkrans.   

Abstract

Much of the research on fescue toxicosis has concentrated on evaluating animal response to grazing endophyte-infected (E+) versus endophyte-free tall fescue or the effects of single toxins such as ergonovine (EN), ergovaline (EV), or ergotamine (ET) on animal performance. Such approaches have eliminated the opportunity to test the possible additive, synergistic, or antagonistic interactions of one or more ergot alkaloids with the other ergot alkaloids found in E+ tall fescue. This study was conducted to determine the effects of simultaneous exposure of pairs of EN, EV, and ET on the kidney adenosine triphosphatase (ATPase) system in vitro. Tests were performed using three separate rat kidney homogenates and were repeated four times at concentrations of 0, 75, and 200 microM. Individually, EN, EV, and ET induced dose-dependent inhibitions of kidney Na(+)/K(+) ATPase, with EN being most potent, followed by purified EV, and then by ET. The ergot alkaloids inhibited Mg(2+) ATPase to a lesser degree than Na(+)/K(+) ATPase, with EN again being the most potent toxin. Simultaneous exposure to any combination of the ergot alkaloid pairs tested (EV + ET, EV + EN, and ET + EN) resulted in significant interactions (P < 0.05), indicating antagonistic effects on the inhibition of Na(+)/K(+) ATPase and Mg(2+) ATPase for most concentration combinations. These interactions suggest that in studies of the effects of any ergot alkaloid on animal performance, effects of other ergot alkaloids may also be present. Effects may not be additive, as was the case in this study, and the presence of one toxin may enhance or hinder the effectiveness of others.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15038775     DOI: 10.1290/1543-706X(2003)039<0395:AEOSEO>2.0.CO;2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  11 in total

1.  Drug points: severe ergotism associated with interaction between ritonavir and ergotamine.

Authors:  L Liaudet; T Buclin; C Jaccard; P Eckert
Journal:  BMJ       Date:  1999-03-20

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Epichloë typhina from toxic tall fescue grasses.

Authors:  C W Bacon; J K Porter; J D Robbins; E S Luttrell
Journal:  Appl Environ Microbiol       Date:  1977-11       Impact factor: 4.792

4.  Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugation.

Authors:  D H Jones; A I Matus
Journal:  Biochim Biophys Acta       Date:  1974-08-09

5.  Assay of Na,K-ATPase in plasma membrane preparations: increasing the permeability of membrane vesicles using sodium dodecyl sulfate buffered with bovine serum albumin.

Authors:  B Forbush
Journal:  Anal Biochem       Date:  1983-01       Impact factor: 3.365

6.  Occurrence of peptide and clavine ergot alkaloids in tall fescue grass.

Authors:  P C Lyons; R D Plattner; C W Bacon
Journal:  Science       Date:  1986-04-25       Impact factor: 47.728

7.  Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine.

Authors:  Naveen K Jain; C S Patil; Amarjit Singh; Shrinivas K Kulkarni
Journal:  Pharmacology       Date:  2003-03       Impact factor: 2.547

8.  Effects of feeding ergovaline on lamb performance in a heat stress environment.

Authors:  M S Gadberry; T M Denard; D E Spiers; E L Piper
Journal:  J Anim Sci       Date:  2003-06       Impact factor: 3.159

9.  Potential drug-drug interactions in the medication of medical patients at hospital discharge.

Authors:  Sabin S Egger; Jürgen Drewe; Raymond G Schlienger
Journal:  Eur J Clin Pharmacol       Date:  2003-02-21       Impact factor: 2.953

10.  Warfarin and amoxicillin/clavulanate drug interaction.

Authors:  Liya Davydov; Marina Yermolnik; Lewis J Cuni
Journal:  Ann Pharmacother       Date:  2003-03       Impact factor: 3.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.